EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Toxicity of CCRT Versus RT Alone in Advanced Esophageal Cancer: A Quasi-Experimental Study

Pulak Dhar, Nowshin Taslima Hossain, Habibur Rahman, Sabbir Noman, Mohosina Asfi Sara, Sumon Paul

Annals of International Medical and Dental Research · 2026-06 · 12 (3) · 78-86

DOI: 10.53339/aimdr.2026.12.3.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of International Medical and Dental Research, 2026-06. Verfasst von Pulak Dhar und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study compared treatment responses and symptomatic improvement between concurrent chemoradiotherapy (CCRT) and radiotherapy (RT) alone in patients with unresectable locally advanced esophageal cancer.

Methods

In this quasi-experimental study, 60 patients (30 per arm) with comparable sociodemographic characteristics were allocated to Arm A (RT alone: 54 Gy/30 fractions) or Arm B (CCRT: RT+cisplatin/ capecitabine). Outcomes included tumor response and symptomatic relief.

Results

The mean age was similar between arms (Arm A: 55.1 ± 9.08 years; Arm B: 55.1 ± 10.32 years), with most patients aged 50–69 years. Male predominance was observed (Arm A: 76.7%; Arm B: 63.3%), though not statistically significant (P = 0.404). Pretreatment dysphagia improved substantially in both arms (>80% response), with no significant difference between groups (P > 0.05). Tumor response rates showed higher complete (20% vs. 10%) and partial responses (66.7% vs. 60%) in Arm B versus Arm A, though differences were not statistically significant (P > 0.05). Stage-stratified analysis revealed similar trends, with no significant differences in partial or stable disease rates across stages (P > 0.05).

Conclusion

CCRT demonstrated numerically superior but statistically comparable tumor response and symptom relief compared to RT alone. Both regimens were effective in palliating dysphagia and other cancer-related symptoms, supporting their use in unresectable locally advanced esophageal cancer.

Zitieren

APA

Dhar, P., Hossain, N. T., Rahman, H., Noman, S., Sara, M. A., & Paul, S. (2026). Efficacy and Toxicity of CCRT Versus RT Alone in Advanced Esophageal Cancer: A Quasi-Experimental Study. Annals of International Medical and Dental Research, 12(3), 78-86. https://doi.org/10.53339/aimdr.2026.12.3.11

Vancouver

Dhar P, Hossain NT, Rahman H, Noman S, Sara MA, Paul S. Efficacy and Toxicity of CCRT Versus RT Alone in Advanced Esophageal Cancer: A Quasi-Experimental Study. Annals of International Medical and Dental Research. 2026;12(3):78-86. doi:10.53339/aimdr.2026.12.3.11

BibTeX
@article{Dhar2026,
  author = {Dhar, Pulak and Hossain, Nowshin Taslima and Rahman, Habibur and Noman, Sabbir and Sara, Mohosina Asfi and Paul, Sumon},
  title = {Efficacy and Toxicity of CCRT Versus RT Alone in Advanced Esophageal Cancer: A Quasi-Experimental Study},
  journal = {Annals of International Medical and Dental Research},
  year = {2026},
  volume = {12},
  number = {3},
  pages = {78--86},
  doi = {10.53339/aimdr.2026.12.3.11}
}
Kostenlos starten →